Skip to content

Clinical trials

Neoplasms by Site trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms by Site Country / region: Italy Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20101
20111
20131
20143
20151
20162
20174
20182
20193
20201
20214
20222
20234
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting10
Active, not recruiting7
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
Eli Lilly and Company4
Hoffmann-La Roche3
Revolution Medicines, Inc.3
Bristol-Myers Squibb2
Novartis Pharmaceuticals2
Sumitomo Pharma America, Inc.2
Abbott1
Boston Scientific Corporation1
Celgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms by Site33
Neoplasms29
Carcinoma10
Carcinoma, Non-Small-Cell Lung10
Lung Diseases10
Lung Neoplasms10
Respiratory Tract Diseases10
Respiratory Tract Neoplasms10
Breast Neoplasms9
Bronchial Neoplasms9

Trials

Showing 51 to 33 of 33. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.